| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | axon extension | 2.09e-06 | 135 | 90 | 7 | GO:0048675 | |
| GeneOntologyBiologicalProcess | regulation of axon extension | 6.28e-06 | 104 | 90 | 6 | GO:0030516 | |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | 6.33e-06 | 299 | 90 | 9 | GO:0060560 | |
| GeneOntologyBiologicalProcess | regulation of extent of cell growth | 1.57e-05 | 122 | 90 | 6 | GO:0061387 | |
| GeneOntologyBiologicalProcess | regulation of cellular component size | TRIM46 PTK2B ISLR2 WDR36 MAP1B L1CAM PLXNA4 TRIOBP PREX1 BAIAP2L2 | 1.67e-05 | 426 | 90 | 10 | GO:0032535 |
| GeneOntologyBiologicalProcess | neuron projection extension | 3.42e-05 | 207 | 90 | 7 | GO:1990138 | |
| GeneOntologyBiologicalProcess | neuron projection development | TRIM46 MAGI2 PTK2B ISLR2 ABI3 WDR36 MAP1B SEMA5B L1CAM PLXNA4 LAMA3 TRIOBP LGR6 HERC1 MAP2K2 PREX1 NCDN | 3.53e-05 | 1285 | 90 | 17 | GO:0031175 |
| GeneOntologyBiologicalProcess | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 4.32e-05 | 16 | 90 | 3 | GO:1902166 | |
| GeneOntologyBiologicalProcess | postsynapse assembly | 5.43e-05 | 93 | 90 | 5 | GO:0099068 | |
| GeneOntologyBiologicalProcess | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 8.68e-05 | 20 | 90 | 3 | GO:1902165 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | TRIM46 ISLR2 ABI3 WDR36 MAP1B SEMA5B L1CAM PLXNA4 LAMA3 TRIOBP LGR6 MAP2K2 | 9.71e-05 | 748 | 90 | 12 | GO:0048667 |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 1.43e-04 | 114 | 90 | 5 | GO:0050772 | |
| GeneOntologyBiologicalProcess | mitochondrion localization | 1.66e-04 | 63 | 90 | 4 | GO:0051646 | |
| GeneOntologyBiologicalProcess | neuron development | TRIM46 MAGI2 PTK2B ISLR2 ABI3 WDR36 MAP1B SEMA5B L1CAM PLXNA4 LAMA3 TRIOBP LGR6 HERC1 MAP2K2 PREX1 NCDN | 1.74e-04 | 1463 | 90 | 17 | GO:0048666 |
| GeneOntologyBiologicalProcess | axonogenesis | TRIM46 ISLR2 WDR36 MAP1B SEMA5B L1CAM PLXNA4 LAMA3 LGR6 MAP2K2 | 1.79e-04 | 566 | 90 | 10 | GO:0007409 |
| GeneOntologyBiologicalProcess | cell morphogenesis | TRIM46 PTK2B ISLR2 ABI3 LATS2 WDR36 MAP1B SEMA5B L1CAM PLXNA4 PKHD1 LAMA3 TRIOBP LGR6 MAP2K2 | 1.92e-04 | 1194 | 90 | 15 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 1.96e-04 | 192 | 90 | 6 | GO:0050770 | |
| GeneOntologyBiologicalProcess | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator | 2.43e-04 | 28 | 90 | 3 | GO:1902254 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | TRIM46 MAGI2 PTK2B ISLR2 ABI3 MAP1B L1CAM PLXNA4 MAP2K2 PREX1 | 3.33e-04 | 612 | 90 | 10 | GO:0010975 |
| GeneOntologyBiologicalProcess | developmental cell growth | 3.49e-04 | 301 | 90 | 7 | GO:0048588 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | TRIM46 PTK2B ISLR2 WDR36 MAP1B L1CAM PLXNA4 TRIOBP PREX1 BAIAP2L2 | 3.60e-04 | 618 | 90 | 10 | GO:0090066 |
| GeneOntologyBiologicalProcess | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage | 3.64e-04 | 32 | 90 | 3 | GO:1902230 | |
| GeneOntologyBiologicalProcess | cell growth | TRIM46 PTK2B ISLR2 WDR36 TAF9B MAP1B SEMA5B L1CAM PLXNA4 WFDC1 | 3.93e-04 | 625 | 90 | 10 | GO:0016049 |
| GeneOntologyBiologicalProcess | regulation of cell growth | 4.37e-04 | 519 | 90 | 9 | GO:0001558 | |
| GeneOntologyBiologicalProcess | regulation of cell size | 4.58e-04 | 225 | 90 | 6 | GO:0008361 | |
| GeneOntologyBiologicalProcess | axon development | TRIM46 ISLR2 WDR36 MAP1B SEMA5B L1CAM PLXNA4 LAMA3 LGR6 MAP2K2 | 4.85e-04 | 642 | 90 | 10 | GO:0061564 |
| GeneOntologyBiologicalProcess | positive regulation of cell-substrate adhesion | 4.94e-04 | 149 | 90 | 5 | GO:0010811 | |
| GeneOntologyBiologicalProcess | regulation of protein polymerization | 5.26e-04 | 231 | 90 | 6 | GO:0032271 | |
| GeneOntologyBiologicalProcess | peptidyl-serine autophosphorylation | 6.64e-04 | 9 | 90 | 2 | GO:0036289 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | MAGI1 MAGI2 PTK2B L1CAM BRD7 PLXNA4 PKHD1 CD55 LAMA3 TRIOBP PREX1 EPHA1 | 6.86e-04 | 927 | 90 | 12 | GO:0030155 |
| Domain | TFIID-31 | 6.72e-05 | 3 | 89 | 2 | IPR003162 | |
| Domain | TFIID-31kDa | 6.72e-05 | 3 | 89 | 2 | PF02291 | |
| Domain | PDZ | 7.10e-04 | 148 | 89 | 5 | SM00228 | |
| Domain | - | 7.54e-04 | 150 | 89 | 5 | 2.30.42.10 | |
| Domain | PDZ | 7.77e-04 | 151 | 89 | 5 | PS50106 | |
| Domain | PDZ | 8.01e-04 | 152 | 89 | 5 | IPR001478 | |
| Domain | WW | 1.46e-03 | 47 | 89 | 3 | PF00397 | |
| Domain | WW | 1.55e-03 | 48 | 89 | 3 | SM00456 | |
| Domain | PROTEIN_KINASE_ATP | 1.55e-03 | 459 | 89 | 8 | PS00107 | |
| Domain | WW_DOMAIN_2 | 1.85e-03 | 51 | 89 | 3 | PS50020 | |
| Domain | WW_DOMAIN_1 | 1.85e-03 | 51 | 89 | 3 | PS01159 | |
| Domain | WW_dom | 1.95e-03 | 52 | 89 | 3 | IPR001202 | |
| Domain | PLAC | 1.97e-03 | 14 | 89 | 2 | PF08686 | |
| Domain | Protein_kinase_ATP_BS | 2.22e-03 | 379 | 89 | 7 | IPR017441 | |
| Domain | Prot_kinase_dom | 2.31e-03 | 489 | 89 | 8 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 2.42e-03 | 493 | 89 | 8 | PS50011 | |
| Domain | Guanylate_kinase_CS | 2.58e-03 | 16 | 89 | 2 | IPR020590 | |
| Domain | TSP_1 | 3.38e-03 | 63 | 89 | 3 | PF00090 | |
| Domain | PLAC | 3.64e-03 | 19 | 89 | 2 | PS50900 | |
| Domain | PLAC | 3.64e-03 | 19 | 89 | 2 | IPR010909 | |
| Domain | TSP1 | 3.69e-03 | 65 | 89 | 3 | SM00209 | |
| Domain | TSP1_rpt | 3.69e-03 | 65 | 89 | 3 | IPR000884 | |
| Domain | TSP1 | 3.69e-03 | 65 | 89 | 3 | PS50092 | |
| Domain | PH_dom-like | 4.23e-03 | 426 | 89 | 7 | IPR011993 | |
| Domain | Kinase-like_dom | 4.31e-03 | 542 | 89 | 8 | IPR011009 | |
| Domain | PDZ | 4.63e-03 | 141 | 89 | 4 | PF00595 | |
| Domain | ADAM_spacer1 | 5.32e-03 | 23 | 89 | 2 | IPR010294 | |
| Domain | GUANYLATE_KINASE_2 | 5.32e-03 | 23 | 89 | 2 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 5.32e-03 | 23 | 89 | 2 | PS00856 | |
| Domain | ADAM_spacer1 | 5.32e-03 | 23 | 89 | 2 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 5.79e-03 | 24 | 89 | 2 | IPR013273 | |
| Domain | Guanylate_kin | 6.77e-03 | 26 | 89 | 2 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 6.77e-03 | 26 | 89 | 2 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 6.77e-03 | 26 | 89 | 2 | IPR008144 | |
| Domain | GuKc | 6.77e-03 | 26 | 89 | 2 | SM00072 | |
| Domain | MetalloPept_cat_dom | 6.83e-03 | 81 | 89 | 3 | IPR024079 | |
| Domain | - | 6.83e-03 | 81 | 89 | 3 | 3.40.390.10 | |
| Domain | IPT | 7.29e-03 | 27 | 89 | 2 | SM00429 | |
| Domain | ACR | 7.29e-03 | 27 | 89 | 2 | SM00608 | |
| Domain | ADAM_Cys-rich | 7.29e-03 | 27 | 89 | 2 | IPR006586 | |
| Domain | TyrKc | 8.57e-03 | 88 | 89 | 3 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 8.57e-03 | 88 | 89 | 3 | IPR020635 | |
| Domain | Rho_GTPase_activation_prot | 8.57e-03 | 88 | 89 | 3 | IPR008936 | |
| Pubmed | BLK PTK2B BCL2L12 LATS2 AP2A2 KCNH2 GRK5 TUT7 PELI3 MAP2K2 SEC23B | 3.72e-06 | 730 | 92 | 11 | 34857952 | |
| Pubmed | TMEPAI family: involvement in regulation of multiple signalling pathways. | 6.92e-06 | 2 | 92 | 2 | 29945215 | |
| Pubmed | Co-expression of activin receptor-interacting protein 1 and 2 in mouse nerve cells. | 6.92e-06 | 2 | 92 | 2 | 23523645 | |
| Pubmed | In vivo functional analysis of the histone 3-like TAF9 and a TAF9-related factor, TAF9L. | 6.92e-06 | 2 | 92 | 2 | 12837753 | |
| Pubmed | MAGI1 copy number variation in bipolar affective disorder and schizophrenia. | 6.92e-06 | 2 | 92 | 2 | 22381734 | |
| Pubmed | 1.19e-05 | 288 | 92 | 7 | 38496616 | ||
| Pubmed | 1.54e-05 | 117 | 92 | 5 | 17145500 | ||
| Pubmed | EphA4-mediated Rho activation via Vsm-RhoGEF expressed specifically in vascular smooth muscle cells. | 2.07e-05 | 3 | 92 | 2 | 12775584 | |
| Pubmed | Human TAFII31 protein is a transcriptional coactivator of the p53 protein. | 2.07e-05 | 3 | 92 | 2 | 7761466 | |
| Pubmed | Essential Role of Linx/Islr2 in the Development of the Forebrain Anterior Commissure. | 2.07e-05 | 3 | 92 | 2 | 29739947 | |
| Pubmed | 2.07e-05 | 3 | 92 | 2 | 29507111 | ||
| Pubmed | MAP1B is required for Netrin 1 signaling in neuronal migration and axonal guidance. | 4.14e-05 | 4 | 92 | 2 | 15186740 | |
| Pubmed | C18 ORF1, a novel negative regulator of transforming growth factor-β signaling. | 4.14e-05 | 4 | 92 | 2 | 24627487 | |
| Pubmed | 4.14e-05 | 4 | 92 | 2 | 31277379 | ||
| Pubmed | Rewiring of RSK-PDZ Interactome by Linear Motif Phosphorylation. | 1.01e-04 | 34 | 92 | 3 | 30726710 | |
| Pubmed | 1.03e-04 | 6 | 92 | 2 | 15509766 | ||
| Pubmed | 1.03e-04 | 6 | 92 | 2 | 26792863 | ||
| Pubmed | Atrophin-1, the DRPLA gene product, interacts with two families of WW domain-containing proteins. | 1.03e-04 | 6 | 92 | 2 | 9647693 | |
| Pubmed | No association between EGR gene family polymorphisms and schizophrenia in the Chinese population. | 1.03e-04 | 6 | 92 | 2 | 20144677 | |
| Pubmed | 1.04e-04 | 547 | 92 | 8 | 37267103 | ||
| Pubmed | Quantifying domain-ligand affinities and specificities by high-throughput holdup assay. | 1.20e-04 | 36 | 92 | 3 | 26053890 | |
| Pubmed | Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. | 1.30e-04 | 37 | 92 | 3 | 24162737 | |
| Pubmed | 1.44e-04 | 7 | 92 | 2 | 11867212 | ||
| Pubmed | Semaphorin-6A controls guidance of corticospinal tract axons at multiple choice points. | 1.44e-04 | 7 | 92 | 2 | 19063725 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | LATS2 WIZ KCNH2 GRK5 L1CAM HELZ2 CHSY1 GRIN2D HERC1 FAAP100 PREX1 | 1.63e-04 | 1105 | 92 | 11 | 35748872 |
| Pubmed | 1.66e-04 | 103 | 92 | 4 | 10819331 | ||
| Pubmed | 1.92e-04 | 8 | 92 | 2 | 18464795 | ||
| Pubmed | Proteomic analysis of beta1-adrenergic receptor interactions with PDZ scaffold proteins. | 1.92e-04 | 8 | 92 | 2 | 16316992 | |
| Pubmed | 2.35e-04 | 963 | 92 | 10 | 28671696 | ||
| Pubmed | 2.46e-04 | 9 | 92 | 2 | 21670103 | ||
| Pubmed | TAF9b (formerly TAF9L) is a bona fide TAF that has unique and overlapping roles with TAF9. | 2.46e-04 | 9 | 92 | 2 | 15899866 | |
| Pubmed | 2.46e-04 | 9 | 92 | 2 | 19909241 | ||
| Pubmed | Dorsal turning of motor corticospinal axons at the pyramidal decussation requires plexin signaling. | 2.46e-04 | 9 | 92 | 2 | 18727829 | |
| Pubmed | 2.74e-04 | 215 | 92 | 5 | 35973513 | ||
| Pubmed | The Semaphorin receptor PlexinA3 mediates neuronal apoptosis during dorsal root ganglia development. | 3.07e-04 | 10 | 92 | 2 | 19020035 | |
| Pubmed | 3.35e-04 | 650 | 92 | 8 | 38777146 | ||
| Pubmed | 3.37e-04 | 225 | 92 | 5 | 12168954 | ||
| Pubmed | 3.42e-04 | 493 | 92 | 7 | 15368895 | ||
| Pubmed | DSCAM regulates delamination of neurons in the developing midbrain. | 3.75e-04 | 11 | 92 | 2 | 32917586 | |
| Pubmed | Linx mediates interaxonal interactions and formation of the internal capsule. | 3.75e-04 | 11 | 92 | 2 | 24930700 | |
| Pubmed | 4.49e-04 | 12 | 92 | 2 | 9621077 | ||
| Pubmed | 4.49e-04 | 12 | 92 | 2 | 17021036 | ||
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 4.53e-04 | 134 | 92 | 4 | 25452129 | |
| Pubmed | 5.30e-04 | 13 | 92 | 2 | 23576434 | ||
| Pubmed | Optimising experimental design for high-throughput phenotyping in mice: a case study. | 5.30e-04 | 13 | 92 | 2 | 20799038 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAGI1 NDUFS7 LATS2 MAP1B NECTIN2 LAMA3 TRIOBP LZTS2 ARL15 MAP2K2 TMEM255B NCDN | 5.55e-04 | 1489 | 92 | 12 | 28611215 |
| Pubmed | NDUFS7 WDR36 WIZ BRD7 HELZ2 PCDHB7 CD55 TRIOBP LZTS2 TAF9 BCOR PREX1 | 5.82e-04 | 1497 | 92 | 12 | 31527615 | |
| Pubmed | 6.17e-04 | 14 | 92 | 2 | 21151955 | ||
| Pubmed | 7.11e-04 | 15 | 92 | 2 | 23782696 | ||
| Pubmed | Regulation of the Mdm2-p53 pathway by the ubiquitin E3 ligase MARCH7. | 7.11e-04 | 15 | 92 | 2 | 29295817 | |
| Pubmed | 7.42e-04 | 1116 | 92 | 10 | 31753913 | ||
| Pubmed | 7.59e-04 | 67 | 92 | 3 | 29254152 | ||
| Pubmed | 8.11e-04 | 16 | 92 | 2 | 24305805 | ||
| Pubmed | Balance between BDNF and Semaphorins gates the innervation of the mammary gland. | 8.11e-04 | 16 | 92 | 2 | 30628891 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 9.21e-04 | 281 | 92 | 5 | 28706196 | |
| Pubmed | 1.03e-03 | 18 | 92 | 2 | 29111974 | ||
| Pubmed | Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development. | 1.03e-03 | 18 | 92 | 2 | 35503090 | |
| Pubmed | Stress-activated protein kinase MKK7 regulates axon elongation in the developing cerebral cortex. | 1.03e-03 | 18 | 92 | 2 | 22090513 | |
| Pubmed | 1.05e-03 | 75 | 92 | 3 | 20637190 | ||
| Pubmed | Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN. | 1.15e-03 | 19 | 92 | 2 | 30385546 | |
| Pubmed | ISLR2 SEMA5B PLXNA4 CHSY1 LGR6 ENKD1 ARID5A BAIAP2L2 TMEM139 | 1.20e-03 | 985 | 92 | 9 | 12975309 | |
| Pubmed | 1.21e-03 | 446 | 92 | 6 | 24255178 | ||
| Pubmed | Cytoplasmic ATXN7L3B Interferes with Nuclear Functions of the SAGA Deubiquitinase Module. | 1.27e-03 | 20 | 92 | 2 | 27601583 | |
| Pubmed | Selective anchoring of TFIID to nucleosomes by trimethylation of histone H3 lysine 4. | 1.27e-03 | 20 | 92 | 2 | 17884155 | |
| Pubmed | TRIM46 ADAMTS19 ARHGAP23 GRK5 TUT7 KIAA0586 NECTIN2 LZTS2 FAAP100 EPHA1 | 1.41e-03 | 1215 | 92 | 10 | 15146197 | |
| Pubmed | 1.41e-03 | 83 | 92 | 3 | 11114734 | ||
| Pubmed | Endoglin Protein Interactome Profiling Identifies TRIM21 and Galectin-3 as New Binding Partners. | 1.53e-03 | 186 | 92 | 4 | 31540324 | |
| Pubmed | 1.54e-03 | 22 | 92 | 2 | 25926459 | ||
| Pubmed | Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. | 1.56e-03 | 86 | 92 | 3 | 10862698 | |
| Pubmed | Proximity labeling reveals dynamic changes in the SQSTM1 protein network. | 1.68e-03 | 322 | 92 | 5 | 39098523 | |
| Pubmed | Thalamic afferents influence cortical progenitors via ephrin A5-EphA4 interactions. | 1.69e-03 | 23 | 92 | 2 | 25480914 | |
| Pubmed | 1.76e-03 | 653 | 92 | 7 | 22586326 | ||
| Pubmed | MEK Is a Key Regulator of Gliogenesis in the Developing Brain. | 1.84e-03 | 24 | 92 | 2 | 22998872 | |
| Pubmed | 2.00e-03 | 25 | 92 | 2 | 23873930 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 2.04e-03 | 861 | 92 | 8 | 36931259 | |
| Pubmed | Ca2+ homeostasis maintained by TMCO1 underlies corpus callosum development via ERK signaling. | 2.16e-03 | 26 | 92 | 2 | 35927240 | |
| Pubmed | 2.16e-03 | 26 | 92 | 2 | 24742657 | ||
| Pubmed | Germline Saturation Mutagenesis Induces Skeletal Phenotypes in Mice. | 2.16e-03 | 26 | 92 | 2 | 33905568 | |
| Pubmed | 2.16e-03 | 26 | 92 | 2 | 17875933 | ||
| Pubmed | 2.48e-03 | 101 | 92 | 3 | 26949739 | ||
| Pubmed | 2.50e-03 | 28 | 92 | 2 | 18617019 | ||
| Pubmed | Alternatively spliced isoforms of WT1 control podocyte-specific gene expression. | 2.50e-03 | 28 | 92 | 2 | 25993318 | |
| Pubmed | 2.55e-03 | 102 | 92 | 3 | 11214970 | ||
| GeneFamily | PDZ domain containing | 1.48e-04 | 152 | 60 | 5 | 1220 | |
| GeneFamily | Beta 4-glycosyltransferases | 1.43e-03 | 17 | 60 | 2 | 425 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 1.79e-03 | 19 | 60 | 2 | 50 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 3.34e-03 | 26 | 60 | 2 | 904 | |
| GeneFamily | PRD class homeoboxes and pseudogenes | 3.54e-03 | 92 | 60 | 3 | 521 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | TRIM46 MAGI2 PTK2B MAP1B ARHGAP23 L1CAM PLXNA4 PAPPA DDC NCDN PDZRN4 | 1.47e-06 | 506 | 91 | 11 | M39067 |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 2.99e-09 | 172 | 93 | 8 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature3_(11)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.91e-07 | 197 | 93 | 7 | a7922f65a8af4a773e4ce80114e4d895a594fa2f | |
| ToppCell | 11.5-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 2.05e-07 | 199 | 93 | 7 | 1a8c77d241bd817a195e1532fd25f51358cb1ff1 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.01e-06 | 158 | 93 | 6 | 8d64c0c9de910a3f4658778642d183c8b9b6f6a2 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 1.71e-06 | 173 | 93 | 6 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-06 | 180 | 93 | 6 | d67d3196e6cc3dcd31023a4dc69310226181d583 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-06 | 180 | 93 | 6 | 573308d43425d9fba20787abdb7f8efefc48efb5 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.69e-06 | 187 | 93 | 6 | 387cb27c8a20031cd87381a9e1172f1f62e1488b | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.86e-06 | 189 | 93 | 6 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | Healthy_donor-B_intermediate|World / disease group, cell group and cell class (v2) | 3.13e-06 | 192 | 93 | 6 | f77007b284e11f8654ad599eef929df7c6c4ebf0 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.22e-06 | 193 | 93 | 6 | 000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature4_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.22e-06 | 193 | 93 | 6 | 01c71aa48875b5ad6c50cc810a72862e72f26ad0 | |
| ToppCell | (1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells|World / Stress and Cell class | 3.42e-06 | 195 | 93 | 6 | 6b5d3ecec0c00ebfc889dc6235390ff53b5c0b6a | |
| ToppCell | 11.5-Distal-Mesenchymal-Airway_Smooth_Muscle|Distal / Age, Tissue, Lineage and Cell class | 3.52e-06 | 196 | 93 | 6 | 05530fe7a5681c2f39b95016cd22ef99d6ac0430 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature3_(11)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.63e-06 | 197 | 93 | 6 | 21a1080e1db3a64f3eccc7aed2b3189332d31038 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.63e-06 | 197 | 93 | 6 | 69d5b8588046d119b5dff9a7fd6f49e97e00a5b7 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.63e-06 | 197 | 93 | 6 | e6cbfa267eb2e05b441fd034786faae07bb0e081 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.96e-06 | 200 | 93 | 6 | f11ae9055e72c938b6c9e52701478b2eee681ac4 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 2.22e-05 | 161 | 93 | 5 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | facs-Marrow-KLS-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-05 | 167 | 93 | 5 | 2812353ff66e76f10bd327ceb0e6b009502a5258 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.65e-05 | 167 | 93 | 5 | 805129f887078340b260aa136b0ba19f2bd6ea03 | |
| ToppCell | facs-Marrow-KLS-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-05 | 167 | 93 | 5 | d15168f46c1599d9fc68a05a7b822c4b439f2987 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.65e-05 | 167 | 93 | 5 | 31cf8bf2eb523f6e7e319620648ff37fc09e2601 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.65e-05 | 167 | 93 | 5 | 3acb18428d1d33ad430c2fd031b1a91baee3c01d | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-pDC|Lung / Manually curated celltypes from each tissue | 2.73e-05 | 168 | 93 | 5 | 90f713dae3fcbd6ca801a019e3861c263ff3366b | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-8|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 2.73e-05 | 168 | 93 | 5 | 00646601548b0fee42ae16bfa5e93603bc7c5129 | |
| ToppCell | AT1-AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.80e-05 | 169 | 93 | 5 | 815474855a70498a74e52f6583113c63b7267a0c | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.97e-05 | 171 | 93 | 5 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-B_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.50e-05 | 177 | 93 | 5 | 320fd77c7c98e9305dcc34a168ec9d674539ed65 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.69e-05 | 179 | 93 | 5 | f65889bf1e41396979cce44a5e63f49dea2bbd9b | |
| ToppCell | NS-moderate-d_16-33-Myeloid-pDC|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.79e-05 | 180 | 93 | 5 | 144818e69613296cde43f29cb8c20899c670b319 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.79e-05 | 180 | 93 | 5 | 97e0dcb7cfbba60a782824c5e23995058609fcd4 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.99e-05 | 182 | 93 | 5 | 0346f81bbb1f309f3e9d063b20547d548d09472c | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.99e-05 | 182 | 93 | 5 | be32b5b8153c1053cbb55f1fccfa27c3ee97c1e1 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-14|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.10e-05 | 183 | 93 | 5 | ffa831f67ed005f05d1b80ebc707e046fc08e22f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.10e-05 | 183 | 93 | 5 | 65f2a5895d166189a095cf7ea9dda171f0419b08 | |
| ToppCell | Mild-Lymphoid-B|Mild / Condition, Lineage, Cell class and cell subclass | 4.10e-05 | 183 | 93 | 5 | 9b64d2d143525e6f48a191facfd101462ff36324 | |
| ToppCell | Mild_COVID-19-B_cell|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 4.10e-05 | 183 | 93 | 5 | dea119e2988e954475f557f0bbe12556a83e81a4 | |
| ToppCell | Mild-Lymphoid-B-|Mild / Condition, Lineage, Cell class and cell subclass | 4.10e-05 | 183 | 93 | 5 | b5740f05a4dcdbbf24f7bf7a3f57ac01a5e75f60 | |
| ToppCell | CV-Severe-3|CV / Virus stimulation, Condition and Cluster | 4.21e-05 | 184 | 93 | 5 | 1c9bda00bb6efd98f68781ca06655bf6c4282f27 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.21e-05 | 184 | 93 | 5 | 3f8a359e40bebe58545f708682e5e5d1b70cf5cb | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.21e-05 | 184 | 93 | 5 | 64bede8db709fd32f40c03265b96f0b12155bb8a | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.32e-05 | 185 | 93 | 5 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.32e-05 | 185 | 93 | 5 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.32e-05 | 185 | 93 | 5 | 609080adb2cfb105bb7b8efb617553833299f371 | |
| ToppCell | droplet-Thymus-nan-24m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-05 | 185 | 93 | 5 | a92bd84e44fc992b7eeefaa2ff8091ed09f0df00 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.32e-05 | 185 | 93 | 5 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | droplet-Thymus-nan-24m-Myeloid-professional_antigen_presenting_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.32e-05 | 185 | 93 | 5 | 877eb127ac797f8a1e1a9e0049fa16cae16cfa35 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.43e-05 | 186 | 93 | 5 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 186 | 93 | 5 | 337f768cc43db2db96ba6495b076006b1a5b0331 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.43e-05 | 186 | 93 | 5 | e378c82ef6d6cb24751515aa499a01372b3e7ccf | |
| ToppCell | moderate-Lymphoid-B_cell|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.43e-05 | 186 | 93 | 5 | fd2c4c3e8929ca5d64f6c5064e5f3d3d6ba07b5f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.43e-05 | 186 | 93 | 5 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | Mild_COVID-19-B_cell-B_cell|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 4.43e-05 | 186 | 93 | 5 | 855a5a00ba2aa1b5c63b8db56d026ddecc546050 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.43e-05 | 186 | 93 | 5 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.54e-05 | 187 | 93 | 5 | b8f88599e22b9b345c7ec3bbecd87a8b2a033f9f | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 4.54e-05 | 187 | 93 | 5 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-05 | 187 | 93 | 5 | ec4b694487cc446999c7b27b119950a4f252c4b3 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.54e-05 | 187 | 93 | 5 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.54e-05 | 187 | 93 | 5 | 530e4e6d91b5c0d9aa4543caa2b734a1674c5788 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-05 | 188 | 93 | 5 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.66e-05 | 188 | 93 | 5 | e9cef856a96a97afac5ecafe2ee91eff0d731e01 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.66e-05 | 188 | 93 | 5 | c29aaae3c5bb7cd6b9b3defd4d27afde3af19ba0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.66e-05 | 188 | 93 | 5 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.66e-05 | 188 | 93 | 5 | f54b063025d80de631382bf5326bc40aab7f7d00 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.66e-05 | 188 | 93 | 5 | 3004e961d214919e08c7cd5f10c3de5cf85b35a3 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.78e-05 | 189 | 93 | 5 | b0244a9d1b5c8ad4708750b691184f3491b13900 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.78e-05 | 189 | 93 | 5 | 975e7aa3b862a8b07c2ab8426a14f5cc54998aca | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-05 | 189 | 93 | 5 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-CD79a_B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-05 | 189 | 93 | 5 | 159769abb867595f0d20a1835b715b3a96d0a38d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.78e-05 | 189 | 93 | 5 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.78e-05 | 189 | 93 | 5 | da9ecc0d7b81c1901f30f97bb44112dc85444a66 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.78e-05 | 189 | 93 | 5 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.78e-05 | 189 | 93 | 5 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.78e-05 | 189 | 93 | 5 | 0abc7a4900cc9033bc1be69b770ccc54a6bf41b4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.90e-05 | 190 | 93 | 5 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 4.90e-05 | 190 | 93 | 5 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | COVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.90e-05 | 190 | 93 | 5 | 07b675befcd1d0a9c90cb17b5d22323468325d51 | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-05 | 190 | 93 | 5 | 19c645884950fd261218c42be60f00a2437164a3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.90e-05 | 190 | 93 | 5 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.90e-05 | 190 | 93 | 5 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.90e-05 | 190 | 93 | 5 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.90e-05 | 190 | 93 | 5 | 5681c211baeed4af82a2bbc13420f6a7b487581c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.90e-05 | 190 | 93 | 5 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.90e-05 | 190 | 93 | 5 | 7ba2be2630183df86de21689289a8620a4cd507e | |
| ToppCell | Control-Lymphoid_B-B_intermediate|Control / Disease group, lineage and cell class | 5.02e-05 | 191 | 93 | 5 | 0082181dbc39c7c4fd3aa34c3ed61439548e844b | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.02e-05 | 191 | 93 | 5 | a15e34ad7dbf3f2f13d5e23ce3ffb6d08fd1f9f0 | |
| ToppCell | LAM-Epithelial-AT1|Epithelial / Condition, Lineage and Cell class | 5.02e-05 | 191 | 93 | 5 | 3457e15d1e9b36a78363d46b320c4ec46b40290a | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.02e-05 | 191 | 93 | 5 | 989bf108c7f2c78dd7f14481570f1819673a5469 | |
| ToppCell | LAM-Epithelial-AT1|LAM / Condition, Lineage and Cell class | 5.02e-05 | 191 | 93 | 5 | 66875b2ec2c510489407f3e433a90cdf74a15094 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.02e-05 | 191 | 93 | 5 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.02e-05 | 191 | 93 | 5 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.02e-05 | 191 | 93 | 5 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | BAL-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.02e-05 | 191 | 93 | 5 | 3e7fbe4af2c23b3b964becde843d2f088ad41c23 | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.02e-05 | 191 | 93 | 5 | bc2f3c4e71e3a55fe76ea03f45746329a8fc81da | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-05 | 191 | 93 | 5 | b9ae5af426e7a1f2652a47700bb168371bd2dec6 | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.15e-05 | 192 | 93 | 5 | d9ff2293358c8b031ba212021012e058014ff472 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature3_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.15e-05 | 192 | 93 | 5 | 7dbe3117a0f58ff2e838963d49f788a59a4351d7 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.15e-05 | 192 | 93 | 5 | 7ae3e1ca8bfc078c0e12a1595ecb0e343dab5d2f | |
| ToppCell | 3'-Child09-12-SmallIntestine-Neuronal-Glial_mature|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.15e-05 | 192 | 93 | 5 | ac507fd7cf3b3e521a15ef03bb4e81eb23807985 | |
| Disease | MAJOR AFFECTIVE DISORDER 2 | 1.69e-05 | 17 | 88 | 3 | C1839839 | |
| Disease | serum gamma-glutamyl transferase measurement | TRIM46 GPATCH1 NECTIN2 PKHD1 TRIOBP LZTS2 ARL15 FAAP100 PMEPA1 ARHGEF15 EPHA1 | 8.63e-05 | 914 | 88 | 11 | EFO_0004532 |
| Disease | cancer antigen 15.3 measurement | 1.83e-04 | 7 | 88 | 2 | EFO_0010585 | |
| Disease | Adenoid Cystic Carcinoma | 2.33e-04 | 100 | 88 | 4 | C0010606 | |
| Disease | glioblastoma (is_marker_for) | 3.11e-04 | 44 | 88 | 3 | DOID:3068 (is_marker_for) | |
| Disease | Dental enamel hypoplasia | 5.69e-04 | 12 | 88 | 2 | EFO_1001304 | |
| Disease | magnesium measurement | 1.02e-03 | 66 | 88 | 3 | EFO_0004845 | |
| Disease | prostate cancer (is_marker_for) | 1.24e-03 | 156 | 88 | 4 | DOID:10283 (is_marker_for) | |
| Disease | diet measurement, HOMA-B | 1.45e-03 | 19 | 88 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | bipolar disorder (is_marker_for) | 1.45e-03 | 19 | 88 | 2 | DOID:3312 (is_marker_for) | |
| Disease | neuroticism measurement | 1.56e-03 | 909 | 88 | 9 | EFO_0007660 | |
| Disease | Anophthalmia-microphthalmia syndrome | 1.78e-03 | 21 | 88 | 2 | cv:C5680330 | |
| Disease | Nerve Degeneration | 1.98e-03 | 83 | 88 | 3 | C0027746 | |
| Disease | Parkinson Disease | 2.12e-03 | 85 | 88 | 3 | C0030567 | |
| Disease | cortical surface area measurement | ALX3 MAGI1 ADAMTS19 TUT7 PKHD1 TRIOBP PAPPA ARHGAP27 ARL15 PMEPA1 PDZRN4 | 2.17e-03 | 1345 | 88 | 11 | EFO_0010736 |
| Disease | central corneal thickness | 2.35e-03 | 309 | 88 | 5 | EFO_0005213 | |
| Disease | Alzheimer disease, high density lipoprotein cholesterol measurement | 2.73e-03 | 26 | 88 | 2 | EFO_0004612, MONDO_0004975 | |
| Disease | serum urea measurement | 2.80e-03 | 195 | 88 | 4 | EFO_0009795 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DGYRLPPPVDCPAPL | 841 | P21709 | |
| PQGLPYCPERSPLLV | 71 | O60512 | |
| CLDSVLGPCLPPPYV | 446 | Q8NCV1 | |
| LGPCLPPPYVRTALH | 451 | Q8NCV1 | |
| CLLGPALGPVPPEAY | 486 | Q03989 | |
| PIPPDPTLCPDNYRR | 11 | Q9H0I2 | |
| PPPARPEYDLVCIGL | 26 | Q9NXU5 | |
| CRLGEEPPPLPYCDQ | 61 | Q6RUI8 | |
| PVDPIVGEPGYCPVR | 356 | Q9NPI1 | |
| TRPPPNMICLLGPSY | 566 | Q9NPI1 | |
| PRLTRFPACGPLEPY | 46 | O95076 | |
| SPRPCSLPIRPCYGL | 151 | Q9HB09 | |
| LPLPICVIPEYAFPR | 431 | Q9NU02 | |
| TPGPLPCSPDTIYED | 741 | O94989 | |
| PDVEPGYLRPLIPAA | 31 | P20711 | |
| PVCTNGERFLYLPPP | 236 | Q6W2J9 | |
| RPLYCPGPRPAAVQS | 901 | Q8TE56 | |
| LLRLLQCYPPPDPAV | 261 | O94973 | |
| QCYPPPDPAVRGRLT | 266 | O94973 | |
| PRPCSELFPLIPNDY | 176 | P34972 | |
| PVYRLPALPCAPPSV | 221 | Q6UXK2 | |
| SLVELAVGRYPIPPP | 256 | P36507 | |
| RPRCQPLPCPYGEAL | 106 | A0A3B3IT52 | |
| CQPLAPGELYRVLPL | 56 | Q6ZMN7 | |
| QYRICENPPCPAGLP | 676 | Q8TE59 | |
| PLAVPEFPVCGLYRI | 31 | O60393 | |
| ITLPPPCSYLEELEP | 491 | O60393 | |
| APENLPPLTPYCRRP | 126 | Q9P2A4 | |
| YPCGEFSPRPPETRV | 181 | Q5HY64 | |
| PPGLPVYLDLCYIPN | 2351 | P46821 | |
| GYEAQEPLCPAVPPR | 66 | Q9BRK4 | |
| KYRSPVPLTPPGCVA | 186 | Q567V2 | |
| PPLPSYGLDLCEFPL | 106 | Q4G0Z9 | |
| ELCRGYPLPFDPDDP | 551 | Q96QZ7 | |
| LCRGYPLPFDPEDPA | 506 | Q86UL8 | |
| RPYGVPVDAPDGCIP | 411 | Q16787 | |
| LFLPPTTVPPECYRD | 246 | Q9UBB6 | |
| PLDVEYGGPDRRCPP | 501 | Q9NRM7 | |
| CERLPAYFVVPTPLP | 236 | Q9C0I1 | |
| LCLPYAPPEGQPAAL | 716 | Q9HBX8 | |
| DTPLYNLEPCEPLPF | 2366 | Q15751 | |
| GRQYQELPRCPAPTP | 1006 | Q12809 | |
| PPYPSGRLTPTCLDM | 241 | Q6UXY1 | |
| PLPECREIYCPAPPQ | 216 | P08174 | |
| GEKVLPPCYRQEPAP | 221 | Q9H425 | |
| EREEFGPRLPPVFCP | 826 | Q9BRR8 | |
| TGPDEDNPKCYPPRI | 86 | Q9HCM2 | |
| PLLPGALVDYPDVLP | 286 | Q9BXM7 | |
| PPGELCPDVLYRTGR | 41 | Q9BUK6 | |
| LPCNPPPSAEPLRIY | 156 | P32004 | |
| CPAELPAVPANRLYP | 351 | Q05215 | |
| VPPACPEPQGCYLEL | 771 | Q13219 | |
| SEPPPLDRVYEIPGL | 41 | Q9BZE1 | |
| PELREYCLPGPVLCA | 336 | Q0VG06 | |
| EEPPPYQGPCTLQLR | 156 | Q969W9 | |
| PCTEPLPRAAEPGYL | 571 | Q9Y5E2 | |
| YGDTTLLREPCPPER | 306 | Q711Q0 | |
| YECVSPDDISLPPLP | 1206 | Q6ZP82 | |
| RPDTCPPELYRGVIA | 456 | P51451 | |
| YEPVICQRPGPSELP | 251 | Q6ZUT9 | |
| CQRPGPSELPLSDYP | 256 | Q6ZUT9 | |
| RVDRSCPYLTVPGPP | 26 | P0C7T7 | |
| LRTCVLRPPGIYGPE | 201 | A6NKP2 | |
| GDRLPKPDLCPPVLY | 641 | Q14289 | |
| NRETLPDPCPVPYGS | 1761 | Q9BYK8 | |
| LDPPFVPDPRAVYCK | 461 | P34947 | |
| KPLEEPAPTYCPERG | 1016 | Q8IY37 | |
| LAGPPIPYTAPELCA | 216 | P0C263 | |
| RLPPGEPCREGYVLS | 6 | Q6NVV3 | |
| TGEPCPEPLRTYGLP | 121 | P17900 | |
| AGPRLPPDRYCLTAP | 111 | Q9HBM6 | |
| SGPRLPPDRYCLTAP | 111 | Q16594 | |
| PLPPRLGICLDYERG | 686 | Q7Z4K8 | |
| YPLPLQPCSRFPVAP | 266 | Q8WV15 | |
| ERECPLCRLVGPYVP | 381 | Q8N2H9 | |
| FIPYREGPIPEPCAL | 186 | Q6ZRT6 | |
| APGLPACLYLRPAAP | 136 | Q6ZUM4 | |
| PQGAPRLYRLCQPPV | 1641 | Q8TCU6 | |
| PLLPPIRTGPYLCEL | 231 | O95785 | |
| TDLPPYPDILLRCGS | 2656 | P08F94 | |
| DRIVPVDIYIPGCPP | 171 | O75251 | |
| AEVPYCDLPRCPPAP | 46 | Q9H2D6 | |
| LPPVQYEPVLCSRPT | 51 | Q15437 | |
| EAPRPYCPKEPGEAR | 96 | Q9Y2V3 | |
| EEYVAPPRGPLPTLQ | 556 | O43734 | |
| IPVVPLRGVDDSYPP | 131 | Q86X52 | |
| PIDCTPPEYILPGSR | 181 | O75153 | |
| PPEYILPGSRERPLC | 186 | O75153 | |
| GCGFPVYPTRILPPR | 176 | Q9NUL5 | |
| AYACLEAVPPPPVLD | 101 | Q9HC57 | |
| SGEARSIPEPPPICY | 176 | Q9P227 | |
| IPEPPPNSGYECQLR | 141 | Q8WUN7 | |
| EPYPPAEPRPLESCC | 546 | Q12815 | |
| SRPCPYSEIPVILPA | 1006 | Q9P283 | |
| LCSIDRPEEGGLPPY | 446 | Q5VYS8 | |
| LEPLTPPPAYDVCFG | 186 | Q8IV31 | |
| YLPARVCTPLPTPQP | 1031 | Q9BVV6 | |
| IPTIPGLVPRYAAPE | 791 | Q8NI36 | |
| PPYQGPCTLQLRDPE | 181 | O15165 | |
| CRAAPPPCPYLDLEP | 1096 | O15399 | |
| ELPCHLLPPVPGLYI | 51 | Q92692 |